Inflammasome activation by Campylobacter jejuni

Journal of Immunology

Volumn 193, Issue 9, 2014, Pages 4548-4557

  Bouwman, Lieneke I ^a   De Zoete, Marcel R ^b,c   Bleumink Pluym, Nancy M C ^a   Flavell, Richard A ^b,c   Van Putten, Jos P M ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; BACTERIAL PROTEIN; BACTERIUM LIPOPOLYSACCHARIDE; CASPASE 11; CRYOPYRIN; CYTOLETHAL DISTENDING TOXIN; FLAGELLIN; INFLAMMASOME; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; TYPE 6 SECRETION SYSTEM NEEDLE PROTEIN; UNCLASSIFIED DRUG; CARRIER PROTEIN; CIAS1 PROTEIN, MOUSE; NLRP3 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; BACTERIAL CAPSULE; BACTERIAL FLAGELLUM; BACTERIUM MUTANT; BONE MARROW DERIVED MACROPHAGE; CAMPYLOBACTER JEJUNI; CARBOHYDRATE SYNTHESIS; CELL DEATH; CELL INVASION; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; HUMAN; HUMAN CELL; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN SECRETION; UPREGULATION; ANIMAL; BIOSYNTHESIS; CAMPYLOBACTERIOSIS; CELL CULTURE; GENETICS; IMMUNOLOGY; MACROPHAGE ACTIVATION; METABOLISM;

ANIMALS; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; CARRIER PROTEINS; CASPASE 1; CELLS, CULTURED; HUMANS; INFLAMMASOMES; INTERLEUKIN-1BETA; MACROPHAGE ACTIVATION; MACROPHAGES; MICE;

EID: 84908139527     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400648     Document Type: Article

References (52)

1. Thornberry, N. A., H. G. Bull, J. R. Calaycay, K. T. Chapman, A. D. Howard, M. J. Kostura, D. K. Miller, S. M. Molineaux, J. R. Weidner, J. Aunins, et al. 1992. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 356: 768-774.
2. Fernandes-Alnemri, T., J. Wu, J. W. Yu, P. Datta, B. Miller, W. Jankowski, S. Rosenberg, J. Zhang, and E. S. Alnemri. 2007. The pyroptosome: a supra-molecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation. Cell Death Differ. 14: 1590-1604.
3. Martinon, F., K. Burns, and J. Tschopp. 2002. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β. Mol. Cell 10: 417-426.
4. Latz, E., T. S. Xiao, and A. Stutz. 2013. Activation and regulation of the inflammasomes. Nat. Rev. Immunol. 13: 397-411.
5. Strowig, T., J. Henao-Mejia, E. Elinav, and R. Flavell. 2012. Inflammasomes in health and disease. Nature 481: 278-286.
6. Franchi, L., R. Muñoz-Planillo, and G. Núñez. 2012. Sensing and reacting to microbes through the inflammasomes. Nat. Immunol. 13: 325-332.
7. Broz, P., and D. M. Monack. 2011. Molecular mechanisms of inflammasome activation during microbial infections. Immunol. Rev. 243: 174-190.
8. Franchi, L., A. Amer, M. Body-Malapel, T. D. Kanneganti, N. Ozören, R. Jagirdar, N. Inohara, P. Vandenabeele, J. Bertin, A. Coyle, et al. 2006. Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1β in Salmonella-infected macrophages. Nat. Immunol. 7: 576-582.
9. Miao, E. A., C. M. Alpuche-Aranda, M. Dors, A. E. Clark, M. W. Bader, S. I. Miller, and A. Aderem. 2006. Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1β via Ipaf. Nat. Immunol. 7: 569-575.
10. Miao, E. A., D. P. Mao, N. Yudkovsky, R. Bonneau, C. G. Lorang, S. E. Warren, I. A. Leaf, and A. Aderem. 2010. Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome. Proc. Natl. Acad. Sci. USA 107: 3076-3080.
11. Compan, V., A. Baroja-Mazo, G. López-Castejón, A. I. Gomez, C. M. Martínez, D. Angosto, M. T. Montero, A. S. Herranz, E. Bazán, D. Reimers, et al. 2012. Cell volume regulation modulates NLRP3 inflammasome activation. Immunity 37: 487-500.
12. + efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity 38: 1142-1153.
13. Yuki, N., K. Susuki, M. Koga, Y. Nishimoto, M. Odaka, K. Hirata, K. Taguchi, T. Miyatake, K. Furukawa, T. Kobata, and M. Yamada. 2004. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lip-ooligosaccharide causes Guillain-Barré syndrome. Proc. Natl. Acad. Sci. USA 101: 11404-11409.
14. Allos, B. M. 2001. Campylobacter jejuni infections: update on emerging issues and trends. Clin. Infect. Dis. 32: 1201-1206.
15. Black, R. E., M. M. Levine, M. L. Clements, T. P. Hughes, and M. J. Blaser. 1988. Experimental Campylobacter jejuni infection in humans. J. Infect. Dis. 157: 472-479.
16. Rathinam, V. A., K. A. Hoag, and L. S. Mansfield. 2008. Dendritic cells from C57BL/6 mice undergo activation and induce Th1-effector cell responses against Campylobacter jejuni. Microbes Infect. 10: 1316-1324.
17. van Alphen, L. B., N. M. Bleumink-Pluym, K. D. Rochat, B. W. van Balkom, M. M. Wösten, and J. P. van Putten. 2008. Active migration into the subcellular space precedes Campylobacter jejuni invasion of epithelial cells. Cell. Microbiol. 10: 53-66.
18. Yao, R., D. H. Burr, and P. Guerry. 1997. CheY-mediated modulation of Campylobacter jejuni virulence. Mol. Microbiol. 23: 1021-1031.
19. Golden, N. J., and D. W. Acheson. 2002. Identification of motility and autoagglutination Campylobacter jejuni mutants by random transposon mutagenesis. Infect. Immun. 70: 1761-1771.
20. Bouwman, L. I., P. Niewold, and J. P. van Putten. 2013. Basolateral invasion and trafficking of Campylobacter jejuni in polarized epithelial cells. PLoS One 8: e54759.
21. van Putten, J. P., L. B. van Alphen, M. M. Wösten, and M. R. de Zoete. 2009. Molecular mechanisms of Campylobacter infection. In Current Topics in Microbiology and Immunology, Vol. 337. Sasakawa, C., ed. Springer Verlag, Berlin, p. 197-229.
22. Bouwman, L. I., and J. P. M. van Putten. 2012. Biology of Campylobacter Infection. In Foodborne and Waterborne Bacterial Pathogens. S. M. Faruque, ed. Caister Academic Press, Norfolk, UK, p. 231-250.
23. Young, K. T., L. M. Davis, and V. J. Dirita. 2007. Campylobacter jejuni: molecular biology and pathogenesis. Nat. Rev. Microbiol. 5: 665-679.
24. Zilbauer, M., N. Dorrell, A. Elmi, K. J. Lindley, S. Schüller, H. E. Jones, N. J. Klein, G. Núnez, B. W. Wren, and M. Bajaj-Elliott. 2007. A major role for intestinal epithelial nucleotide oligomerization domain 1 (NOD1) in eliciting host bactericidal immune responses to Campylobacter jejuni. Cell. Microbiol. 9: 2404-2416.
25. de Zoete, M. R., A. M. Keestra, P. Roszczenko, and J. P. van Putten. 2010. Activation of human and chicken toll-like receptors by Campylobacter spp. Infect. Immun. 78: 1229-1238.
26. Wassenaar, T. M., M. Engelskirchen, S. Park, and A. Lastovica. 1997. Differential uptake and killing potential of Campylobacter jejuni by human peripheral monocytes/macrophages. Med. Microbiol. Immunol. (Berl.) 186: 139-144.
27. Hickey, T. E., G. Majam, and P. Guerry. 2005. Intracellular survival of Campylobacter jejuni in human monocytic cells and induction of apoptotic death by cytholethal distending toxin. Infect. Immun. 73: 5194-5197.
28. Kiehlbauch, J. A., R. A. Albach, L. L. Baum, and K. P. Chang. 1985. Phagocytosis of Campylobacter jejuni and its intracellular survival in mononuclear phagocytes. Infect. Immun. 48: 446-451.
29. Watson, R. O., and J. E. Galan. 2008. Campylobacter jejuni survives within epithelial cells by avoiding delivery to lysosomes. PLoS Pathog. 4: e14.
30. Jones, M. A, S. Tötemeyer, D. J. Maskell, C. E. Bryant, and P. A. Barrow. 2003. Induction of proinflammatory responses in the human monocytic cell line THP-1 by Campylobacter jejuni. Infect. Immun. 71: 2626-2633.
31. Siegesmund, A. M., M. E. Konkel, J. D. Klena, and P.F. Mixter. 2004. Campylobacter jejuni infection of differentiated THP-1 macrophages results in in-terleukin 1 beta release and caspase-1-independent apoptosis. Microbiology 150: 561-569.
32. Sun, X., D. Threadgill, and C. Jobin. 2012. Campylobacter jejuni induces colitis through activation of mammalian target of rapamycin signaling. Gastroenterology 142: 86-95.e5.
33. Islam, D., N. Ruamsap, A. Aksomboon, P. Khantapura, A. Srijan, and C. J. Mason. Immune responses to Campylobacter (C jejuni or C coli) infections: a two-year study of US forces deployed to Thailand. APMIS. In press.
34. Weischenfeldt, J., and B. Porse. 2008. Bone Marrow-Derived Macrophages (BMM): Isolation and Applications. CSH Protoc. 2008: pdb.prot5080.
35. van Mourik, A., N. M. Bleumink-Pluym, L. van Dijk, J. P. van Putten, and M. M. Wösten. 2008. Functional analysis of a Campylobacter jejuni alkaline phosphatase secreted via the Tat export machinery. Microbiology 154: 584-592.
36. Keestra, A. M., and J. P. van Putten. 2008. Unique properties of the chicken TLR4/MD-2 complex: selective lipopolysaccharide activation of the MyD88-dependent pathway. J. Immunol. 181: 4354-4362.
37. Hickey, T. E., S. Baqar, A. L. Bourgeois, C. P. Ewing, and P. Guerry. 1999. Campylobacter jejuni-stimulated secretion of interleukin-8 by INT407 cells. Infect. Immun. 67: 88-93.
38. Elliott, K. T, I. B. Zhulin, J. A. Stuckey, and V. J. DiRita. 2009. Conserved residues in the HAMP domain define a new family of proposed bipartite energy taxis receptors. J. Bacteriol. 191: 375-387.
39. Broz, P., K. Newton, M. Lamkanfi, S. Mariathasan, V. M. Dixit, and D. M. Monack. 2010. Redundant roles for inflammasome receptors NLRP3 and NLRC4 in host defense against Salmonella. J. Exp. Med. 207: 1745-1755.
40. Atianand, M. K., E. B. Duffy, A. Shah, S. Kar, M. Malik, and J. A. Harton. 2011. Francisella tularensis reveals a disparity between human and mouse NLRP3 inflammasome activation. J. Biol. Chem. 286: 39033-39042.
41. Dinarello, C. A. 2009. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 27: 519-550.
42. von Moltke, J., J. S. Ayres, E. M. Kofoed, J. Chavarría-Smith, and R. E. Vance. 2013. Recognition of bacteria by inflammasomes. Annu. Rev. Immunol. 31: 73-106.
43. de Zoete, M. R., and R. A. Flavell. 2013. Interactions between Nod-like receptors and intestinal bacteria. Front. Immunol. 4: 462.
44. Yang, J., Y. Zhao, J. Shi, and F Shao. 2013. Human NAIP and mouse NAIP1 recognize bacterial type III secretion needle protein for inflammasome activation. Proc. Natl. Acad. Sci. USA 110: 14408-14413.
45. Zhao, Y, J. Yang, J. Shi, Y N. Gong, Q. Lu, H. Xu, L. Liu, and F. Shao. 2011. The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature 477: 596-600.
46. Rayamajhi, M., D. E. Zak, J. Chavarria-Smith, R. E. Vance, and E. A Miao. 2013. Cutting edge: mouse NAIP1 detects the type III secretion system needle protein. J. Immunol. 191: 3986-3989.
47. Cunha, L. D., and D. S. Zamboni. 2013. Subversion of inflammasome activation and pyroptosis by pathogenic bacteria. Front. Cell. Infect. Microbiol. 3: 76.
48. Hagar, J. A., D. A. Powell, Y Aachoui, R. K Ernst, and E. A. Miao. 2013. Cytoplasmic LPS activates caspase-11: implications in TLR4-independent en-dotoxic shock. Science 341: 1250-1253.
49. Kayagaki, N, M. T. Wong, I. B. Stowe, S. R. Ramani, L. C. Gonzalez, S. Akashi-Takamura, K. Miyake, J. Zhang, W. P. Lee, A. Muszyński, et al. 2013. Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science 341: 1246-1249.
50. Edwards, L. A., K. Nistala, D. C. Mills, H. N. Stephenson, M. Zilbauer, B. W. Wren, N Dorrell, K. J. Lindley, L. R. Wedderburn, and M. Bajaj-Elliott. 2010. Delineation of the innate and adaptive T-cell immune outcome in the human host in response to Campylobacter jejuni infection. PLoS One 5: e15398.
51. Sims, J. E., and D. E. Smith. 2010. The IL-1 family: regulators of immunity. Nat. Rev. Immunol. 10: 89-102.
52. Al-Banna, N, R. Raghupathy, and M. J. Albert. 2008. Correlation of proinflammatory and anti-inflammatory cytokine levels with histopathological changes in an adult mouse lung model of Campylobacter jejuni infection. Clin. Vaccine Immunol. 15: 1780-1787.